dc.contributor.author | Udina-Cortés, Carlos | |
dc.contributor.author | Fernández-Carnero, Josué | |
dc.contributor.author | Arribas Romano, Alberto | |
dc.contributor.author | Cuenca Zaldívar , Juan Nicolás | |
dc.contributor.author | Villafañe, Jorge Hugo | |
dc.contributor.author | Castro-Marrero, Jesús | |
dc.contributor.author | Alguacil-Diego, Isabel María | |
dc.date.accessioned | 2021-10-28T08:31:42Z | |
dc.date.available | 2021-10-28T08:31:42Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 0025-7974 | spa |
dc.identifier.uri | http://hdl.handle.net/10641/2530 | |
dc.description.abstract | Background:
To evaluate the effectiveness of non-invasive neuro-adaptive electrostimulation (NAE) therapy for treating chronic pain and disability in patients with fibromyalgia.
Method/design:
A prospective, randomized, sham-controlled study was conducted in 37 women with fibromyalgia. Participants were randomly assigned to receive either active NAE (n = 20) or stimulation with a sham device (n = 17). Participants in the experimental arm received eight 30-minute sessions over 4 weeks (2 sessions per week). The sham group received eight 30-minute sessions of sham stimulation. Therapeutic effects on pain relief, disability, and quality of life were evaluated using outcome measures at baseline, at 4 weeks, and after 3 months’ follow-up.
Results:
The findings indicated a significant reduction of pain in the active NAE group compared with the sham group immediately post-intervention, with a difference on the Visual Analog Scale (VAS) of 3 points (P = .001), and at 3 months’ follow-up (P = .02). There were significant intragroup differences between the groups (P < .05) at post-intervention. After the intervention, both groups presented significant reductions on the Fibromyalgia Impact Questionnaire (FIQ) with respect to baseline (P = .004), but not at the 3-month follow-up. In the conditioned pain modulation (CPM) in thumb variable we found significant differences between the groups at the 3-month follow-up (P = .02). No additional benefits for conditioned pain modulation and disability were observed between groups at the 3-month follow-up. Furthermore, anxiety/depression and catastrophizing improved in both groups, but no differences between groups were found.
Conclusions:
In this fibromyalgia cohort, NAE therapy significantly improved pain and quality of life at 4 weeks, but not at 3-month follow-up, compared with the sham stimulation group. Future investigations are needed in larger populations to confirm these findings. | spa |
dc.language.iso | eng | spa |
dc.publisher | Medicine | spa |
dc.rights | Atribución-NoComercial-SinDerivadas 3.0 España | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.subject | electrostimulation | spa |
dc.subject | fibromyalgia | spa |
dc.subject | pain | spa |
dc.subject | rehabilitation | spa |
dc.title | Effects of neuro-adaptive electrostimulation therapy on pain and disability in fibromyalgia A prospective, randomized, double-blind study. | spa |
dc.type | journal article | spa |
dc.type.hasVersion | AM | spa |
dc.rights.accessRights | open access | spa |
dc.description.extent | 364 KB | spa |
dc.identifier.doi | 10.1097/MD.0000000000023785 | spa |
dc.relation.publisherversion | https://journals.lww.com/md-journal/Fulltext/2020/12180/Effects_of_neuro_adaptive_electrostimulation.96.aspx | spa |